Biohaven Ltd. (BHVN)
NYSE: BHVN · Real-Time Price · USD
15.96
0.00 (0.00%)
Jul 2, 2026, 4:00 PM EDT - Market closed
Biohaven Market Cap
Biohaven has a market cap or net worth of $2.4 billion as of July 6, 2026. Its market cap has increased by 61.62% in one year.
Market Cap
2.40B
Enterprise Value
2.34B
1-Year Change
61.62%
Ranking
Category
Stock Price
$15.96
Market Cap Chart
Since September 23, 2022, Biohaven's market cap has increased from $261.58M to $2.40B, an increase of 818.64%. That is a compound annual growth rate of 79.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 2.40B | 60.41% |
| Dec 31, 2025 | 1.50B | -60.34% |
| Dec 31, 2024 | 3.78B | 9.99% |
| Dec 29, 2023 | 3.43B | 262.97% |
| Dec 30, 2022 | 946.07M | 261.68% |
| Sep 23, 2022 | 261.58M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trevi Therapeutics | 2.55B |
| Nurix Therapeutics | 2.48B |
| AbCellera Biologics | 2.48B |
| Intellia Therapeutics | 2.45B |
| Mineralys Therapeutics | 2.44B |
| Kodiak Sciences | 2.41B |
| Nektar Therapeutics | 2.40B |
| Vericel | 2.40B |